TARGETED MOLECULAR THERAPY OF HEPATOCELLULAR CARCINOMA
Mohamed Salah Mohamed Shiha;
Abstract
Hepatocellular carcinoma (HCC, also called malignant hepatoma) is a primary malignancy (cancer) of the liver. Most cases of HCC are secondary to either a viral hepatitide infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of
Other data
| Title | TARGETED MOLECULAR THERAPY OF HEPATOCELLULAR CARCINOMA | Other Titles | العلاج الجزيئي المُستهدِف لسرطان خلايا الكبد | Authors | Mohamed Salah Mohamed Shiha | Keywords | TARGETED MOLECULAR THERAPY OF HEPATOCELLULAR CARCINOMA | Issue Date | 2011 | Description | Hepatocellular carcinoma (HCC, also called malignant hepatoma) is a primary malignancy (cancer) of the liver. Most cases of HCC are secondary to either a viral hepatitide infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.